Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Single Cell Developmental Classification of B Cell Precursor Acute Lymphoblastic Leukemia (BCP ALL) Reveals Link Between Phenotype, Signaling, and Drug Response

Kara L. Davis, DO, Nikolay Samusik, PhD, Astraea Jager, Sean C. Bendall, PhD, Erin F. Simonds, PhD, Wendy J. Fantl, PhD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 488.

https://doi.org/10.1182/blood.V124.21.488.488

Published: 2014

Journal Articles

Mass Cytometric Analysis of AML Stem and Early Progenitor Cells Reveals Karyotype and Genotype-Specific Immunophenotypes That May Represent Targets for Antibody-Directed Therapies

Gregory K. Behbehani, MD PhD, Wendy J. Fantl, PhD, Bruno C Medeiros, MD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 2380.

https://doi.org/10.1182/blood.V124.21.2380.2380

Published: 2014

Journal Articles

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Gregory K. Behbehani, MD PhD, Rachel Finck, B.S., Nikolay Samusik, PhD, Pier Federico Gherardini, PhD, Kunju J Sridhar, PhD, Wendy J. Fantl, PhD, Peter L. Greenberg, MD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 1903.

https://doi.org/10.1182/blood.V124.21.1903.1903

Published: 2014

Journal Articles

Mass Cytometric Analysis of AML Stem and Early Progenitor Cells Reveals Karyotype and Genotype-Specific Cell Cycle Properties That Correlate with Known Responses to Chemotherapy

Gregory K. Behbehani, MD PhD, Wendy J. Fantl, PhD, Bruno C Medeiros, MD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 2359.

https://doi.org/10.1182/blood.V124.21.2359.2359

Published: 2014

Journal Articles

Network-Based Discovery of Prognostic Markers in Pediatric AML by Multi-Dimensional Single Cell Mass Cytometry

Karen Sachs, PhD, Garry P. Nolan, PhD, Wendy J. Fantl, PhD, Erin F. Simonds, PhD, Sean C. Bendall, PhD, Kara L. Davis, DO

Blood (2012) 120 (21): 1411.

https://doi.org/10.1182/blood.V120.21.1411.1411

Published: 2012

Journal Articles

Mass Cytometry Organizes the Heterogeneity of Pediatric B Cell Acute Lymphoblastic Leukemia

Kara L. Davis, DO, Erin F. Simonds, Sean C Bendall, PhD, Wendy J. Fantl, PhD, Garry P. Nolan, PhD

Blood (2011) 118 (21): 753.

https://doi.org/10.1182/blood.V118.21.753.753

Published: 2011

Journal Articles

Application of Mass Cytometry to Measure Proliferation During Normal and Malignant Hematopoietic Differentiation

Gregory K. Behbehani, MD, PhD, Sean C Bendall, PhD, Matthew Clutter, PhD, Bruno C. Medeiros, MD, Wendy J. Fantl, PhD, Garry P. Nolan, PhD

Blood (2011) 118 (21): 4782.

https://doi.org/10.1182/blood.V118.21.4782.4782

Published: 2011

Journal Articles

Single Cell Network Profiling (SCNP) of IFN-α Signaling Pathways In Peripheral Blood Mononuclear Cells From Healthy Donors: Implications for Disease Characterization, Treatment Selection, and Drug Discovery

Diane Longo, PhD, Erik Evensen, PhD, Wendy J. Fantl, PhD, Zoltan Pos, PhD, Francesco Marincola, MD, Alessandra Cesano, MD

Blood (2010) 116 (21): 4867.

https://doi.org/10.1182/blood.V116.21.4867.4867

Published: 2010

Journal Articles

Single Cell Profiling of B Cell Receptor Signaling and Apoptosis Networks in Chronic Lymphocytic Leukemia: Association with in Vitro Sensitivity to Fludarabine Monophosphate (F-ara-A).

Erik Evensen, PhD, Adam Palazzo, Ying-Wen Huang, MS, Alessandra Cesano, MD, PhD, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD, PhD, Wendy J. Fantl, PhD

Blood (2009) 114 (22): 1263.

https://doi.org/10.1182/blood.V114.22.1263.1263

Published: 2009

Journal Articles

FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations.

M. D. Minden, MD, PhD, Steven M. Kornblau, MD, David B. Rosen, PhD, Aileen Cleary Cohen, MD, PhD, Urte Gayko, PhD, Santosh Putta, PhD, John Woronicz, PhD, Wendy J. Fantl, PhD, Alessandra Cesano, MD, PhD

Blood (2009) 114 (22): 1588.

https://doi.org/10.1182/blood.V114.22.1588.1588

Published: 2009

Journal Articles

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

Steven Kornblau, M.D., M. D. Minden, MD, PhD, David B. Rosen, PhD, Santosh Putta, PhD, Aileen C. Cohen, MD, PhD, Todd Covey, Wendy J. Fantl, PhD, Urte Gayko, PhD, Alessandra Cesano, MD, PhD

Blood (2009) 114 (22): 1582.

https://doi.org/10.1182/blood.V114.22.1582.1582

Published: 2009

Journal Articles

Single Cell Network Profiling (SCNP) to Evaluate the Mechanism of Action of ON 01910.Na, A Novel Clinical Trial Stage Compound.

David M. Soper, PhD, Ying-Wen Huang, MS, Francois Wilhelm, MD, Ph.D, S. C. Cosenza, E. Premkumar Reddy, PhD, Alessandra Cesano, MD, PhD, Peter L Greenberg, MD, Wendy J. Fantl, PhD

Blood (2009) 114 (22): 3827.

https://doi.org/10.1182/blood.V114.22.3827.3827

Published: 2009

Journal Articles

Single Cell Network Profiling as a Tool to Identify AML Chemotherapy Resistant Cell Phenotypes Under In Vivo Therapeutic Pressure.

Alessandra Cesano, MD, PhD, John Woronicz, PhD, Aileen Cleary Cohen, MD, PhD, Todd Covey, Santosh Putta, PhD, Urte Gayko, PhD, Wendy J. Fantl, PhD, S.M. Kornblau, M.D.

Blood (2009) 114 (22): 397.

https://doi.org/10.1182/blood.V114.22.397.397

Published: 2009

Journal Articles

Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia.

David B. Rosen, PhD, James A Cordeiro, David M. Soper, PhD, Ying-Wen Huang, MS, Donna E. Hogge, MD, PhD, Roland B. Walter, MD, PhD, Alessandra Cesano, MD, PhD, Wendy J. Fantl, PhD

Blood (2009) 114 (22): 2745.

https://doi.org/10.1182/blood.V114.22.2745.2745

Published: 2009

Journal Articles

Classification of Acute Myeloid Leukemia (AML) Based On Apoptosis and Myeloid Signaling Networks.

David B. Rosen, PhD, M. D. Minden, MD, PhD, Santosh Putta, PhD, Todd Covey, Ying W. Huang, MSc, Alessandra Cesano, MD, PhD, Wendy J. Fantl, PhD

Blood (2009) 114 (22): 325.

https://doi.org/10.1182/blood.V114.22.325.325

Published: 2009

Journal Articles

High Level Phosphatase Activity Revealed in Chronic Lymphocytic Leukemia Cells That Use Mutated Immunoglobulin Heavy Chain Variable Region Genes and Lack High-Level Expression of the Zeta-Associated Protein 70 (ZAP-70).

Wendy J. Fantl, PhD, Rolla L. Yafawi, BS, Santosh K. Putta, PhD, Ying-Wen Huang, MS, Helen L. Francis-Lang, PhD, Rassenti Z. Laura, PhD, Aileen Cleary Cohen, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2007) 110 (11): 743.

https://doi.org/10.1182/blood.V110.11.743.743

Published: 2007

NARROW

Single Cell Developmental Classification of B Cell Precursor Acute Lymphoblastic Leukemia (BCP ALL) Reveals Link Between Phenotype, Signaling, and Drug Response

Mass Cytometric Analysis of AML Stem and Early Progenitor Cells Reveals Karyotype and Genotype-Specific Immunophenotypes That May Represent Targets for Antibody-Directed Therapies

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Mass Cytometric Analysis of AML Stem and Early Progenitor Cells Reveals Karyotype and Genotype-Specific Cell Cycle Properties That Correlate with Known Responses to Chemotherapy

Network-Based Discovery of Prognostic Markers in Pediatric AML by Multi-Dimensional Single Cell Mass Cytometry

Mass Cytometry Organizes the Heterogeneity of Pediatric B Cell Acute Lymphoblastic Leukemia

Application of Mass Cytometry to Measure Proliferation During Normal and Malignant Hematopoietic Differentiation

Single Cell Network Profiling (SCNP) of IFN-α Signaling Pathways In Peripheral Blood Mononuclear Cells From Healthy Donors: Implications for Disease Characterization, Treatment Selection, and Drug Discovery

Single Cell Profiling of B Cell Receptor Signaling and Apoptosis Networks in Chronic Lymphocytic Leukemia: Association with in Vitro Sensitivity to Fludarabine Monophosphate (F-ara-A).

FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations.

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

Single Cell Network Profiling (SCNP) to Evaluate the Mechanism of Action of ON 01910.Na, A Novel Clinical Trial Stage Compound.

Single Cell Network Profiling as a Tool to Identify AML Chemotherapy Resistant Cell Phenotypes Under In Vivo Therapeutic Pressure.

Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia.

Classification of Acute Myeloid Leukemia (AML) Based On Apoptosis and Myeloid Signaling Networks.

High Level Phosphatase Activity Revealed in Chronic Lymphocytic Leukemia Cells That Use Mutated Immunoglobulin Heavy Chain Variable Region Genes and Lack High-Level Expression of the Zeta-Associated Protein 70 (ZAP-70).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only